Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07343128Phase 3Completed
Phase 3, randomised, single-blind trial of lidocaine and dexamethasone in fibromyalgia (FM) (2 arms), sponsored by Şanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesi. Primary endpoint: Fibromyalgia Impact Questionnaire Revised Total Score at 1 week. Started Jun 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07343128.